Bloomberg Law Reports
Anti‐Commercial Bribery Laws in China and Their Enforcement in the Pharmaceutical Industry
November 2010
Anti‐commercial bribery laws have a huge impact on the daily business operation of companies in China. At present, relevant laws and regulations in China are very general and vague and, as a result, enforcement agencies at local levels have a great deal of discretion in determining what types of activities constitute commercial bribery, and what penalties will be imposed.
Contacts
Capabilities
Suggested News & Insights
Sixteen Sidley Partners Selected to Serve on Law360’s 2026 Editorial BoardsMarch 30, 2026Sidley Advises Shield AI on Acquisition of AechelonMarch 26, 2026Fifth Circuit Holds U.S. FTC’s In-House Adjudication of Deceptive Advertising Claim Unconstitutional Under JarkesyMarch 24, 2026Ninth Circuit Opens Door to FCA Liability for Alleged 340B OverchargesMarch 19, 2026Fourth Circuit Highlights Tougher Path to Dismissal of FCA Cases Post-SuperValuMarch 18, 2026Sidley Secures Early Termination of Corporate Probation in Clean Air Act Matter for Leading Aftermarket Automotive CompanyMarch 16, 2026
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory